Argatroban is a hepatically metabolized, direct thrombin inhibitor used for prophylaxis or
treatment of thrombosis in heparin-induced thrombocytopenia (HIT) and for patients with or …

Heparin-induced thrombocytopenia (HIT) is a rare but potentially severe complication of
heparin therapy that is strongly associated with venous and arterial thrombosis (HIT and …

Argatroban, a direct thrombin inhibitor used for thromboprophylaxis or treatment in heparin-
induced thrombocytopenia (HIT), is routinely monitored using the activated partial …

BACKGROUND Manufacturer recommendations for argatroban use in the setting of heparin-
induced thrombocytopenia (HIT) state that the dosage should be titrated to a goal activated …

Argatroban, a highly selective direct thrombin inhibitor, is indicated for use as an
anticoagulant for the treatment and prophylaxis of thrombosis in patients with heparin …

Argatroban is a first‐line anticoagulant for patients with heparin‐induced thrombocytopenia
(HIT). Published data on practical aspects of its use in HIT are lacking. We aim to establish …

BACKGROUND: Argatroban, a direct thrombin inhibitor, is used for prophylaxis or treatment
of thrombosis in heparin-induced thrombocytopenia (HIT). The recommended initial dose is …

When heparin-induced thrombocytopenia (HIT) is reasonably suspected, all heparin
exposures should be eliminated and an alternative nonheparin anticoagulant expeditiously …

Background: Heparin-induced thrombocytopenia (HIT) can lead to catastrophic
thromboembolic complications and requires treatment with an alternative, rapidly active …

Background Argatroban is considered to be an alternative anticoagulant of choice in
patients with heparin-induced thrombocytopenia (HIT) and renal impairment. The …